Brussels - Delayed Quote EUR

Fagron NV (FAGR.BR)

Compare
16.70
+0.08
+(0.48%)
At close: 5:35:13 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
762,991.00
762,991.00
683,881.00
573,808.00
555,971.00
Cost of Revenue
430,379.00
430,379.00
397,716.00
326,312.00
309,242.00
Gross Profit
332,612.00
332,612.00
286,165.00
247,496.00
246,729.00
Operating Expense
219,903.00
219,903.00
184,999.00
157,574.00
154,352.00
Operating Income
112,709.00
112,709.00
101,166.00
89,922.00
92,377.00
Net Non Operating Interest Income Expense
-17,655.00
-17,655.00
-12,487.00
-11,279.00
-13,549.00
Pretax Income
84,445.00
84,445.00
87,769.00
76,820.00
73,715.00
Tax Provision
13,401.00
13,401.00
17,703.00
15,442.00
13,678.00
Net Income Common Stockholders
70,547.00
70,547.00
69,612.00
61,004.00
59,601.00
Diluted NI Available to Com Stockholders
70,547.00
70,547.00
69,612.00
61,004.00
59,601.00
Basic EPS
0.97
0.97
0.96
0.84
0.83
Diluted EPS
0.97
0.97
0.96
0.84
0.82
Basic Average Shares
73,000.00
73,000.00
72,875.00
72,643.00
72,089.39
Diluted Average Shares
73,000.00
73,000.00
72,886.00
72,715.00
72,385.00
Total Operating Income as Reported
108,633.00
108,633.00
97,909.00
87,438.00
88,738.00
Total Expenses
650,282.00
650,282.00
582,715.00
483,886.00
463,594.00
Net Income from Continuing & Discontinued Operation
70,547.00
70,547.00
69,612.00
61,004.00
59,601.00
Normalized Income
77,099.23
77,099.23
68,405.42
61,902.88
62,700.61
Interest Income
5,324.00
5,324.00
4,064.00
1,421.00
753.00
Interest Expense
15,156.00
15,156.00
10,620.00
8,006.00
10,854.00
Net Interest Income
-17,655.00
-17,655.00
-12,487.00
-11,279.00
-13,549.00
EBIT
99,601.00
99,601.00
98,389.00
84,826.00
84,569.00
EBITDA
134,123.00
134,123.00
129,686.00
111,309.00
112,051.00
Reconciled Cost of Revenue
430,379.00
430,379.00
397,716.00
326,312.00
309,242.00
Reconciled Depreciation
34,522.00
34,522.00
31,297.00
26,483.00
27,482.00
Net Income from Continuing Operation Net Minority Interest
70,547.00
70,547.00
69,612.00
61,004.00
59,601.00
Total Unusual Items Excluding Goodwill
-7,791.00
-7,791.00
1,512.00
-1,125.00
-3,806.00
Total Unusual Items
-7,791.00
-7,791.00
1,512.00
-1,125.00
-3,806.00
Normalized EBITDA
141,914.00
141,914.00
128,174.00
112,434.00
115,857.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,238.77
-1,238.77
305.42
-226.13
-706.39
12/31/2020 - 10/5/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

183490.KQ Enzychem Lifesciences Corporation
1,507.00
-0.13%
 
CCC.JO Cilo Cybin Holdings Ltd
450.00
+18.42%
 
HLUN-A.CO H. Lundbeck A/S
32.50
+0.62%
 
MEDXF Medexus Pharmaceuticals Inc.
3.0500
+5.54%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.8500
-5.55%
 
APH.L Alliance Pharma plc
61.10
-0.16%
 
VTRS Viatris Inc.
11.72
-0.68%
 
ACB.TO Aurora Cannabis Inc.
5.66
-2.41%
 
ZTS Zoetis Inc.
164.41
-1.15%
 
WEED.TO Canopy Growth Corporation
3.2000
-6.98%